Immunogenotypic and Viral Analyzes of Lethal Midline Granuloma

致死性中线肉芽肿的免疫基因型和病毒分析

基本信息

项目摘要

So-called lethal midline granuloma is of great clinical and theoretical interest. The etiology of lethal midline granuloma is unknown and the pathogenesis is variable, with debate as to precise classification and natural history. In this study, we reported immunopathological, immunogenotypic and viral features in 11 cases of lethal midline granuloma. The histopathological diagnosis of their biopsy specimens was initially polymorphic reticulosis or midline malignant reticulosis. Immunohistologic study of the specimens revealed that immature or atypical cells had phenotypes of T-cells, CD2, CD3, CD4, CD8 in 9 cases and of natural killer cells, CD2 and CD56 in other 2 cases. Those cells were also found to be positive for HLA-DR,which indicated that they were activated cells. Immunohistology in T-cells, however, was not able to give a similar clue to clonarity as it was possible within B-cells neoplasms by immunophenotyping the light chains. With the establishment of cDNA probes for the T- … More cell receptor genes it was possible to analyze neoplasms of lymphocyte origin for lineage and clonality. The Southern blot analysis of 7 cases showed rearrangement of TCR gene, TCRbeta or TCRgamma chain in 5 cases, whereas none of them showed rearragement of immunoglobulin heavy chain. These findings represented conclusive evidence for a monoclonal T-cell proliferation within the majority of lethal midline granuloma. In addition, phenotypic and immunogenotypic analyzes revealed that some of the disease originated in natural killer cell lineage. EpsteinBarr virus (EBV) DNA was detected in the nasal tumour biopsy specimens by Southern blotting and in vitro hybridisation with simultaneous detection of EBV determined nuclear antigen (EBNA) and T cell surface markers by two color immunofluorescence. Further immuno-fluorescence and northern blotting revealed that EBNA2 gene and also latent membrane protein gene were expressed in the nasal tumour cells. The patients had high titres of antibodies to EBV.These findings suggest that lethal midline granuloma is causally associated with EBV.On the ground of immungenotypi and viral studies, lethal midline granuloma histologically diagnosed as polymorphic reticulosis/midline malignant reticulosis are proven to be a Epstein-Barr virus associated T-cell lymphoproliferative disorder. Less
所谓的致命性中线肉芽肿具有很高的临床和理论价值。致死性中线肉芽肿的病因尚不清楚,发病机制多种多样,关于确切的分类和自然病史也存在争议。在这项研究中,我们报告了11例致死性中线肉芽肿的免疫病理、免疫表型和病毒特征。他们的活检标本的组织病理学诊断最初是多形性网织或中线恶性网织。免疫组织化学结果显示,未成熟或异型细胞中有9例T细胞表型为CD2、CD3、CD4、CD8,2例为自然杀伤细胞表型CD2、CD56。这些细胞也被发现为HLA-DR阳性,这表明它们是激活的细胞。然而,T细胞的免疫组织学不能给出类似的克隆性线索,因为在B细胞肿瘤中,通过免疫表型轻链可以给出类似的线索。T-…基因探针的建立更多的细胞受体基因,有可能分析起源于淋巴细胞的肿瘤的谱系和克隆性。Southern杂交7例,5例TCR基因、TCRbeta或TCRGamma链重排,未见免疫球蛋白重链重排。这些发现为大多数致死性中线肉芽肿中的单克隆性T细胞增殖提供了确凿证据。此外,表型和免疫表型分析显示,一些疾病起源于自然杀伤细胞谱系。采用Southern杂交和体外杂交技术检测鼻部肿瘤活检标本中EB病毒DNA,并用双色免疫荧光法同时检测EB病毒核抗原(EBNA)和T细胞表面标志。进一步的免疫荧光和Northern印迹显示EBNA2基因和潜伏膜蛋白基因在鼻腔肿瘤细胞中均有表达。这些患者具有较高的EBV抗体滴度。这些发现表明致死性中线肉芽肿与EBV有因果关系。根据免疫分型和病毒研究,组织学诊断为多形性网织/中线恶性网状增生症的致死性中线肉芽肿被证明是一种EB病毒相关性T细胞增生性疾病。较少

项目成果

期刊论文数量(30)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Harabuchi, Y.: "Lethalmidline granuloma after lymphomatoid papulosis" Cancer. 70. 835-839 (1992)
Harabuchi, Y.:“淋巴瘤样丘疹病后的致死中线肉芽肿”癌症。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yamanaka, N.: "The grognostic value of Ki-67 antigen innon-Hodgkin lymphoma of Waldeyer ring and nasal Cavity" Cancer. 70. 2342-2349 (1992)
Yamanaka, N.:“Ki-67 抗原在韦氏环和鼻腔非霍奇金淋巴瘤中的预后价值”癌症。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yamanaka,N.: "The prognostic value of Ki-67antigen in non-Hodgkin lymhoma of Waldeyer ring and nasal cavity" Cancer. 70. 2342-2349 (1992)
Yamanaka,N.:“Ki-67 抗原在韦氏环和鼻腔非霍奇金淋巴瘤中的预后价值”癌症。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Yamanaka, N.: "Lethal midline granuloma (in Japanese)" Nihon Iji Shinpo. 3624. 119 (1993)
Yamanaka, N.:“致死性中线肉芽肿(日语)”Nihon Iji Shinpo。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Harabuchi Y.: "Lethal midline granulama after lymphomatoid papulosis" Cancer. 70. 835-839 (1992)
Harabuchi Y.:“淋巴瘤样丘疹病后致命的中线肉芽肿”癌症。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

YAMANAKA Noboru其他文献

YAMANAKA Noboru的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('YAMANAKA Noboru', 18)}}的其他基金

Pathogenesis research of pediatric intractable otitis media and viral-bacterial interaction
小儿顽固性中耳炎发病机制及病毒-细菌相互作用研究
  • 批准号:
    21592165
  • 财政年份:
    2009
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
A study of pathogenesis of intractable otitis media and activation of natural and specific immunities against pathogens
顽固性中耳炎发病机制及病原体自然特异性免疫激活的研究
  • 批准号:
    19591987
  • 财政年份:
    2007
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Immunological and molecular-biological studies on pathogenesis and treatments of intractable obits media
顽固性脓肿发病机制和治疗的免疫学和分子生物学研究
  • 批准号:
    17591797
  • 财政年份:
    2005
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
MOLECULAR-BIOLOGICAL APPROACHES TO CARCINOGENESIS AND METASTASIS OF HEAD AND NECK CANCER AND THEIR APPLICATIONS TO IMMUNO-GENETIC THERAPY
头颈癌致癌和转移的分子生物学方法及其在免疫遗传学治疗中的应用
  • 批准号:
    13470362
  • 财政年份:
    2001
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
EFFECT OF ROLL DIAMETER AND ROLLING SPEED IN ROLLING FOR FLATTENING AN ARC -SHAPED FGM
辊径和辊压速度对圆弧形FGM压扁的影响
  • 批准号:
    10650134
  • 财政年份:
    1998
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
MOLECULAR-BIOLOGICAL APPROACHES TO HEAD AND NECK CANCER AND THE CLINICAL APPLICATION
头颈癌的分子生物学方法及其临床应用
  • 批准号:
    10470359
  • 财政年份:
    1998
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B).
STUDY OF THE PATHOGENESIS IN RECURRENT OTITIS MEDIA AND THE DEVELOPMENT OF PREVENTIVE VACCINE
复发性中耳炎的发病机制研究及预防疫苗的研制
  • 批准号:
    07671880
  • 财政年份:
    1995
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
YOUNG'S MODULUS AND INTERNAL FRICTION OF FUNCTIONALLY GRADIENT MATERIAL AT ROOM AND HIGHER TEMPERATURE
功能梯度材料在室温和高温下的杨氏模量和内摩擦
  • 批准号:
    07650804
  • 财政年份:
    1995
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Immunologic、 Virologic、 and Bacteriologec Studies of Tonsillar Focal Infections and Their Clinical Applications
扁桃体局灶性感染的免疫学、病毒学和细菌学研究及其临床应用
  • 批准号:
    63570814
  • 财政年份:
    1988
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似海外基金

The molecular basis of T cell receptor cross-reactivity between MHC and MR1
MHC 和 MR1 之间 T 细胞受体交叉反应的分子基础
  • 批准号:
    DP240102905
  • 财政年份:
    2024
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Discovery Projects
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
  • 批准号:
    23K28188
  • 财政年份:
    2024
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
CAREER: Understanding the Impact of Dephosphorylation Kinetics and Adapter Specificity on Synthetic T Cell Receptor Signaling and Function
职业:了解去磷酸化动力学和接头特异性对合成 T 细胞受体信号传导和功能的影响
  • 批准号:
    2339172
  • 财政年份:
    2024
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Continuing Grant
Special Public T Cell Receptor Sequences that Predict Outcomes for Cancer Patients
预测癌症患者预后的特殊公共 T 细胞受体序列
  • 批准号:
    10577518
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
Machine Learning of Disease Biomarkers from B and T cell Receptor Repertoires
来自 B 和 T 细胞受体库的疾病生物标志物的机器学习
  • 批准号:
    23H03498
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Impact of T cell receptor signaling on memory CD8+ T cell stemness
T 细胞受体信号传导对记忆 CD8 T 细胞干性的影响
  • 批准号:
    10676407
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
T cell receptor cross-reactivity and structural basis of virus immune escape
T细胞受体交叉反应性和病毒免疫逃逸的结构基础
  • 批准号:
    22KK0277
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
    Fund for the Promotion of Joint International Research (Fostering Joint International Research (A))
T-cell receptor mimic affinity reagent generation using an in vivo novel immunogen strategy
使用体内新型免疫原策略生成 T 细胞受体模拟亲和试剂
  • 批准号:
    10599584
  • 财政年份:
    2023
  • 资助金额:
    $ 1.34万
  • 项目类别:
Mechanical regulation of T cell receptor and co-receptor responses in cancer immunotherapy
癌症免疫治疗中 T 细胞受体和辅助受体反应的机械调节
  • 批准号:
    10530023
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
Inhibition of T-cell Receptor Signaling for Treatment of Adult T-cell Leukemia Lymphoma
抑制 T 细胞受体信号转导治疗成人 T 细胞白血病淋巴瘤
  • 批准号:
    10684172
  • 财政年份:
    2022
  • 资助金额:
    $ 1.34万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了